Psyence Biomedical Ltd. (Nasdaq: PBM) ('Psyence BioMed” or the 'Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
As such, exercising an in-the-money call option would allow the trader to buy shares at a discount to the current market ...
In relation to the 2028 Notes, the Put Option has been validly exercised by Noteholders for an aggregate nominal amount of €399,700,000.00 (i.e. a total redemption amount (including interest accrued) ...
The court has ruled in favor of former ADOR CEO Min Hee Jin over HYBE regarding the put option (stock purchase claim right) worth approximately 25.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results